tiprankstipranks
Trending News
More News >
Pfizer (DE:PFE)
XETRA:PFE
Germany Market

Pfizer (PFE) Ratios

Compare
198 Followers

Pfizer Ratios

DE:PFE's free cash flow for Q4 2025 was $0.70. For the 2025 fiscal year, DE:PFE's free cash flow was decreased by $ and operating cash flow was $-0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.16 1.16 1.17 0.91 1.22
Quick Ratio
0.87 0.87 0.92 0.69 1.00
Cash Ratio
0.03 0.03 0.02 0.06 <0.01
Solvency Ratio
0.12 0.10 0.12 0.06 0.36
Operating Cash Flow Ratio
0.32 0.32 0.30 0.18 0.69
Short-Term Operating Cash Flow Coverage
3.36 3.36 1.83 0.84 9.98
Net Current Asset Value
$ -78.49B$ -78.49B$ -74.54B$ -93.88B$ -50.03B
Leverage Ratios
Debt-to-Assets Ratio
0.32 0.32 0.31 0.31 0.18
Debt-to-Equity Ratio
0.78 0.78 0.76 0.80 0.36
Debt-to-Capital Ratio
0.44 0.44 0.43 0.44 0.27
Long-Term Debt-to-Capital Ratio
0.42 0.42 0.39 0.40 0.25
Financial Leverage Ratio
2.41 2.41 2.42 2.54 2.06
Debt Service Coverage Ratio
2.77 2.50 1.81 0.85 9.04
Interest Coverage Ratio
5.78 5.78 5.33 2.40 30.33
Debt to Market Cap
0.42 0.46 0.43 0.44 0.12
Interest Debt Per Share
12.33 12.33 12.37 12.95 6.44
Net Debt to EBITDA
3.95 4.39 3.64 7.11 0.84
Profitability Margins
Gross Profit Margin
70.33%70.33%65.77%50.95%61.89%
EBIT Margin
16.29%16.29%17.47%5.49%35.85%
EBITDA Margin
26.82%24.12%28.49%16.05%40.90%
Operating Profit Margin
24.67%24.67%25.91%8.89%37.43%
Pretax Profit Margin
12.02%12.02%12.61%1.78%34.61%
Net Profit Margin
12.42%12.42%12.60%3.58%31.26%
Continuous Operations Profit Margin
12.44%12.44%12.65%3.65%31.30%
Net Income Per EBT
103.32%103.32%99.96%201.61%90.31%
EBT Per EBIT
48.71%48.71%48.67%19.99%92.49%
Return on Assets (ROA)
3.73%3.73%3.76%0.94%15.90%
Return on Equity (ROE)
8.67%8.99%9.09%2.40%32.79%
Return on Capital Employed (ROCE)
9.02%9.02%9.67%2.96%24.21%
Return on Invested Capital (ROIC)
8.84%8.84%9.28%2.80%21.49%
Return on Tangible Assets
9.34%9.34%8.97%2.27%30.61%
Earnings Yield
5.01%5.49%5.34%1.31%10.92%
Efficiency Ratios
Receivables Turnover
5.27 5.27 4.31 3.83 6.91
Payables Turnover
3.54 3.54 3.87 4.35 5.62
Inventory Turnover
1.74 1.74 2.01 2.87 4.26
Fixed Asset Turnover
2.91 2.91 3.46 3.14 6.17
Asset Turnover
0.30 0.30 0.30 0.26 0.51
Working Capital Turnover Ratio
7.71 9.43 43.85 25.56 7.68
Cash Conversion Cycle
175.70 175.70 172.21 138.74 73.59
Days of Sales Outstanding
69.26 69.26 84.77 95.27 52.86
Days of Inventory Outstanding
209.46 209.46 181.84 127.31 85.72
Days of Payables Outstanding
103.02 103.02 94.40 83.84 64.99
Operating Cycle
278.72 278.72 266.61 222.57 138.58
Cash Flow Ratios
Operating Cash Flow Per Share
2.06 2.06 2.25 1.54 5.22
Free Cash Flow Per Share
1.60 1.60 1.74 0.85 4.64
CapEx Per Share
0.46 0.46 0.51 0.69 0.58
Free Cash Flow to Operating Cash Flow
0.78 0.78 0.77 0.55 0.89
Dividend Paid and CapEx Coverage Ratio
0.94 0.94 1.03 0.66 2.40
Capital Expenditure Coverage Ratio
4.45 4.45 4.38 2.23 9.04
Operating Cash Flow Coverage Ratio
0.17 0.17 0.19 0.12 0.84
Operating Cash Flow to Sales Ratio
0.19 0.19 0.20 0.15 0.29
Free Cash Flow Yield
5.85%6.41%6.55%2.95%9.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
19.97 18.21 18.74 76.17 9.16
Price-to-Sales (P/S) Ratio
2.48 2.26 2.36 2.73 2.86
Price-to-Book (P/B) Ratio
1.79 1.64 1.70 1.83 3.00
Price-to-Free Cash Flow (P/FCF) Ratio
17.10 15.59 15.28 33.90 11.04
Price-to-Operating Cash Flow Ratio
13.25 12.09 11.79 18.67 9.82
Price-to-Earnings Growth (PEG) Ratio
-0.93 -4.31 0.07 -0.82 0.22
Price-to-Fair Value
1.79 1.64 1.70 1.83 3.00
Enterprise Value Multiple
13.20 13.76 11.93 24.11 7.84
Enterprise Value
221.51B 207.77B 216.22B 230.45B 321.80B
EV to EBITDA
13.20 13.76 11.93 24.11 7.84
EV to Sales
3.54 3.32 3.40 3.87 3.21
EV to Free Cash Flow
24.41 22.89 21.98 48.08 12.36
EV to Operating Cash Flow
18.92 17.75 16.97 26.49 11.00
Tangible Book Value Per Share
-6.73 -6.73 -6.26 -7.69 0.21
Shareholders’ Equity Per Share
15.22 15.22 15.57 15.77 17.06
Tax and Other Ratios
Effective Tax Rate
-0.04 -0.04 >-0.01 -1.05 0.10
Revenue Per Share
11.01 11.01 11.23 10.55 17.89
Net Income Per Share
1.37 1.37 1.42 0.38 5.59
Tax Burden
1.03 1.03 1.00 2.02 0.90
Interest Burden
0.74 0.74 0.72 0.32 0.97
Research & Development to Revenue
0.19 0.19 0.17 0.18 0.11
SG&A to Revenue
0.00 0.00 0.18 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 0.00 0.01 <0.01 <0.01
Income Quality
1.50 1.51 1.58 4.01 0.93
Currency in USD